Westlake Chemical Partners PE ratio WLKP
Share price divided by earnings per share over the last twelve months, since 2016.
- Today, Oct 23, 2026
- 13.0×
- 10-year median
- 13.7×
- Against its 10-year history
- 31st
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 7.6× to 17.5×
- Peer median
- 19.8×
Westlake Chemical Partners' PE ratio is 13.0× as of Oct 23, 2026: a share price of $21.15 against $1.63 of earnings per share over the last twelve months.
That is below its ten-year median of 13.7×, lower than on 69% of days in the last ten years.
Over that time it ranged from 7.6× in Mar 2020 to 17.5× in May 2017.
The median for 7 specialty chemicals stocks of a similar size is 19.8×.
PE ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 13.0× | 12.8× | 16.7× |
| 2025 | 13.3× | 12.7× | 15.6× |
| 2024 | 13.3× | 12.9× | 15.2× |
| 2023 | 13.4× | 10.7× | 14.1× |
| 2022 | 10.7× | 9.6× | 14.2× |
| 2021 | 13.9× | 11.1× | 15.0× |
| 2020 | 12.3× | 7.6× | 15.1× |
| 2019 | 15.7× | 13.1× | 15.7× |
| 2018 | 14.3× | 12.8× | 15.9× |
| 2017 | 15.4× | 13.2× | 17.5× |
| 2016 | 14.2× | 11.8× | 15.2× |
Against its peers
Companies in Chemicals - Specialty nearest Westlake Chemical Partners' size, closest first, today.
| Company | PE ratio |
|---|---|
| WLKPWestlake Chemical Partners | 13.0× |
| LXULSB Industries | 19.8× |
| GPREGreen Plains | 8.8× |
| LXFRLuxfer | 59.6× |
| REXREX AMERICAN RESOURCES | 10.9× |
| ALTOAlto Ingredients | 5.4× |
| SXTSensient Technologies | 35.8× |
| AXTAAxalta Coating Systems | 21.1× |
| Peer median | 19.8× |
Where Westlake Chemical Partners ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Westlake Chemical Partners
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.